Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Supercritical Fluid Extractor

By Drug Discovery Trends Editor | August 21, 2012

Supercritical Fluid Technologies (SFT) introduces a new bench top supercritical fluid extractor (SFE), the model SFT-110. This latest addition to the SFE product line builds upon the strengths of its popular predecessor, the SFT-100.  The completely redesigned restrictor valve with integrated micrometer allows for very precise flow control, which is essential for demanding applications. A completely removable oven lid and large side panel allow the user easy access to the high pressure vessel. An indicator light on the SFT-10 pump module alerts the user to proper operation of the Peltier pre-cooler, ensuring CO2 is maintained in the liquid state. A robust outlet from the restrictor ensures that users will not accidentally damage the outlet tube when inserting it into the collection container.

Supercritical fluid extraction has become a popular alternative to traditional extraction methods that use organic solvents. Fast, efficient extraction of a variety of materials may be achieved using supercritical carbon dioxide. The SFT-110 SFE is well suited for both research and process development applications. Precise control of temperature, pressure, and flow rate is essential for successful, reproducible extractions. The use of dual sapphire syringe pump technology, integrated pre-heaters, and precise flow control provides the precision required to achieve these goals. Process parameters developed in the laboratory are the key to the successful scale-up to pilot or production scale equipment.

Supercritical Fluid Technologies

 


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50